Last reviewed · How we verify
NCT03172286
Radiofrequency Technic's Impact on Perineal Postpartum Pain
NA trial testing Radiofrequencer in Delivery; Injury in 62 participants. Status unknown.
1 April 2018
Quick facts
| Lead sponsor | Assistance Publique Hopitaux De Marseille |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 62 |
| Start date | 10 April 2017 |
| Primary completion | 1 April 2018 |
| Estimated completion | 31 December 2018 |
| Sites | 1 location across France |
Drugs / interventions tested
- Radiofrequencer
Conditions studied
- Delivery; Injury — all drugs for Delivery; Injury →
Sponsor
Assistance Publique Hopitaux De Marseille — full company profile →
Who can join
18 and older, female only, with Delivery; Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study in the postpartum period reveals that among women who delivered vaginally and having perineal lesions, between 95 and 100% of them suffer from perineal pain (episiotomy, tears from 1st to 4th degree) to 24 hours of vaginal delivery; and between 60 and 91% 7 days after delivery. Severe pain that is not taken into account can become chronic pain. It has physical and psychological consequences. It is therefore essential to prevent these risks in young mothers. The main objective of this study is to assess the efficacy of radiofrequency treatment on perineal pain postpartum, after a vaginal delivery, instrumented or not, in patients with perineal lesions. A double-blind randomized prospective single-center study will be conducted on patients delivering at Marseille's north hospital. Women who gave birth to the North hospital site, with perineal lesions (tears, episiotomy) will be invited to enroll in the study. Patients will be then randomized into two groups, one with radiofrequency treatment, the other without treatment with radiofrequency. The duration of inclusion is provided over 6 months. Each topic will be followed over a period of 1 month. The total study duration is 7 months. The expected results are a significant reduction in pain scores during the first days postpartum in women with perineal alteration caused by a vaginal delivery instrumented or not. Also an improvement in the quality of life of patients during the first days.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Capacitive-resistive radiofrequency therapy to treat postpartum perineal pain: A randomized study.
Bretelle F, Fabre C, Golka M, Pauly V, et al · · 2020 · cited 16× · PMID 32339169 · DOI 10.1371/journal.pone.0231869
Verify or expand the search:
- PubMed search for NCT03172286
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Delivery; Injury
Currently open trials in the same condition.
- NCT06664112 — Delivery Outcomes by AIDA (Artificial Intelligence Dystocia Algorithm) Analysis · recruiting
Other Assistance Publique Hopitaux De Marseille trials
Trials by the same sponsor.
- NCT07521644 — Dysbiosis of Methanogenic Archaea and Nanoarchaea in the Oral Microbiome · NA · not yet recruiting
- NCT07357025 — Resting-State fMRI Study of Functional Connectivity After Gamma Knife Radiosurgery in Trigeminal Neuralgia · NA · not yet recruiting
- NCT07356661 — Evaluation of the Efficacy of Neurofeedback Technique Based on EEG Desynchronization in Epileptic Patients · NA · not yet recruiting
- NCT07399327 — Biomarkers of Response to SEEG Thermocoagulation · NA · not yet recruiting
- NCT06999499 — Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03172286 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assistance Publique Hopitaux De Marseille
- Last refreshed: 1 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03172286.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing